Large subretinal hemorrhage after intravitreal bevacizumab (Avastin®) for age-related macular degeneration
- Cite this article as:
- Chieh, J.J. & Fekrat, S. Ann Ophthalmol (2007) 39: 51. doi:10.1007/BF02697326
- 7 Downloads
We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular agerelated macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.